First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study
Bristol-Myers Squibb
Susanna Hegewisch-Becker; Guillermo Mendez; Joseph Chao; Radim Nemecek; Kynan Feeney; Eric Van Cutsem; Salah-Eddin Al-Batran; Wasat Mansoor; Nicholas Maisey; Roberto Pazo Cid; Matthew Burge; David Perez-Callejo; R William Hipkin; Sourav Mukherjee; Ming Lei; Hao Tang; Satyendra Suryawanshi; Ronan J Kelly; Niall C Tebbutt